NMPA ACCEPTS NEW INDICATION APPLICATION FOR SACITUZUMAB TIRUMOTECAN (SAC-TMT) AS FIRST-LINE TREATMENT FOR ADVANCED TNBC

Reuters · 2d ago

Please log in to view news